Balihodzic, A
CRISPR/Cas9 screening for cancer drivers in NSCLC
3. Innsbruck – Graz Lung Cancer Workshop; MARCH 8-9, 2024; Werfenweng. 2024.
[Oral Communication]
Balihodzic, A; Jäger, V; Reinisch, A; Jost, PJ; Strasser, A; Dengler MA
BCL-XL plays a role in determining lung cancer cell fate upon chemotherapy
Doctoral Day of Medical University of Graz; FEB 8, 2024; Graz. 2024.
[Oral Communication]
Balihodzic, A
Identifying synthetic lethal interactions with MCL-1 inhibition in lung cancer.
2. Lung Cancer Retreat Innsbruck-Graz; MARCH 10-11, 2023; Schladming, AUSTRIA. 2023.
[Oral Communication]
Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Balihodzic, A; Fernandez-Hernandez, FJ; Jäger, V; Vosberg, S; Tonietto, M; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Doctoral Day of Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Jäger, V; Flasch, B; Vosberg, S; Fernandez-Hernandez, F; Balihodzic, A; Kienreich, S; Stanzer, S; Herold, M; Kargl, J; Dengler, M; Jost, P
Uncovering innovative molecular targets for lung cancer therapy on the highly recurrent chromosomal gain of 1q21
OeGHO- & AHOP-Frühjahrstagung 2023; Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 30-APR 1; Innsbruck, Austria. 2023.
[Poster]
FullText
Jäger, V; Flasch, B; Vosberg, S; Fernandez-Hernandez, F; Balihodzic, A; Kienreich, S; Stanzer, S; Herold, M; Kargl, J; Dengler, M; Jost, P
Uncovering innovative molecular targets for lung cancer therapy on the highly recurrent chromosomal gain of 1q21
Doctoral Day of Medical University of Graz; FEB 9; Graz, AUSTRIA. 2023.
[Poster]
Jäger, V; Flasch, B; Vosberg, S; Fernandez-Hernandez, F; Tonietto M; Balihodzic, A; Kienreich, S; Stanzer, S; Herold, M; Kindler, O; Maitz, K; Kargl, J; Dengler, M; Jost, P
Oncogene or tumor-suppressor? - Functional characterization of the plasma membrane rupture mediator Ninjurin 1 in lung cancer
13th Scientific Retreat of the DK-MCD; SEP 25-27; Seggau, AUSTRIA. 2023.
[Oral Communication]
Balihodzic, A; Prinz, F; Jonas, K; Barth, DA; Dengler, MA; Slaby, O; Jost, PJ; Klec, C; Pichler, M
A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2022; 15: 37-67.-OeGHO- & AHOP-Frühjahrstagung; APRIL 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Balihodzic, A; Prinz, F; Jonas, K; Barth, DA; Dengler, MA; Slaby, O; Jost, PJ; Klec, C; Pichler, M.
A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma
8. International Student Congress Graz; JUNE 16-18, 2022; Graz, AUSTRIA. 2022.
[Poster]
Prinz, F; Jonas, K; Klec, C; Balihodzic, A; Pichler, M
Double-stranded RNA triggers cancer cells’ innate immune responses and leads to the upregulation of immunosuppressive immune checkpoint molecules.
11th Scientific Retreat of the DK-MCD; SEP 27-29, 2021; Seggau, AUSTRIA. 2021.
[Oral Communication]
Prinz, F; Jonas, K; Klec, C; Balihodzic, A; Pichler, M
Double-stranded RNA triggers cancer cells’ innate immune responses and leads to the upregulation of immunosuppressive immune checkpoint molecules.
11th Scientific Retreat of the DK-MCD; SEP 27-29, 2021; Seggau, AUSTRIA. 2021.
[Poster]